Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 549
5
Diseases
17
Unique genes
0.233
Avg. similarity score
Hidradenoma
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hidradenoma
Mucoepidermoid carcinoma of submandibular gland
Floor of mouth mucoepidermoid carcinoma
Warthin tumor
Gestational trophoblastic disease
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Hidradenoma | 4 | 4 | 4 |
| Mucoepidermoid carcinoma of submandibular gland | 4 | 4 | 16 |
| Floor of mouth mucoepidermoid carcinoma | 3 | 3 | 4 |
| Warthin tumor | 3 | 3 | 2 |
| Gestational trophoblastic disease | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CRTC1 | 4 / 5 | Floor of mouth mucoepidermoid carcinoma, Hidradenoma, Mucoepidermoid carcinoma of submandibular gland, Warthin tumor |
| MAML2 | 4 / 5 | Floor of mouth mucoepidermoid carcinoma, Hidradenoma, Mucoepidermoid carcinoma of submandibular gland, Warthin tumor |
| POU5F1 | 3 / 5 | Gestational trophoblastic disease, Hidradenoma, Mucoepidermoid carcinoma of submandibular gland |
| EWSR1 | 2 / 5 | Hidradenoma, Mucoepidermoid carcinoma of submandibular gland |
| HRAS | 2 / 5 | Floor of mouth mucoepidermoid carcinoma, Mucoepidermoid carcinoma of submandibular gland |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| SHC1 events in ERBB4 signaling | Reactome | 2 / 14 | 101× | 1.70e-4 | 2.89e-3 ✓ sig. |
| GRB2 events in ERBB2 signaling | Reactome | 2 / 14 | 101× | 1.70e-4 | 2.89e-3 ✓ sig. |
| Human T-cell leukemia virus 1 infection | KEGG | 4 / 224 | 12.6× | 2.32e-4 | 3.68e-3 ✓ sig. |
| Signaling by ERBB2 TMD/JMD mutants | Reactome | 2 / 22 | 64.2× | 4.28e-4 | 5.93e-3 ✓ sig. |
| ATP-dependent chromatin remodeling | KEGG | 3 / 117 | 18.1× | 5.55e-4 | 7.24e-3 ✓ sig. |
| Signaling by ERBB2 KD Mutants | Reactome | 2 / 25 | 56.5× | 5.55e-4 | 7.25e-3 ✓ sig. |
| Circadian Clock | Reactome | 2 / 28 | 50.5× | 6.98e-4 | 8.62e-3 ✓ sig. |
| Human papillomavirus infection | KEGG | 4 / 333 | 8.5× | 1.04e-3 | 1.17e-2 ✓ sig. |
| Transcriptional activation of mitochondrial biogenesis | Reactome | 2 / 51 | 27.7× | 2.31e-3 | 2.12e-2 ✓ sig. |
| Viral carcinogenesis | KEGG | 3 / 205 | 10.3× | 2.79e-3 | 2.42e-2 ✓ sig. |
| Defective Mismatch Repair Associated With MSH6 | Reactome | 1 / 2 | 353× | 2.83e-3 | 2.44e-2 ✓ sig. |
| Defective Mismatch Repair Associated With MSH3 | Reactome | 1 / 2 | 353× | 2.83e-3 | 2.44e-2 ✓ sig. |
| Thermogenesis | KEGG | 3 / 234 | 9.1× | 4.06e-3 | 3.16e-2 ✓ sig. |
| Defective Mismatch Repair Associated With MSH2 | Reactome | 1 / 3 | 235× | 4.24e-3 | 3.26e-2 ✓ sig. |
| RAS GTPase cycle mutants | Reactome | 1 / 3 | 235× | 4.24e-3 | 3.26e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 7 / 1,208 | 6.4× | 5.07e-5 | 1.87e-3 ✓ sig. |
| regulation of cell cycle | GO:0051726 | 4 / 262 | 16.8× | 7.78e-5 | 2.57e-3 ✓ sig. |
| chromatin remodeling | GO:0006338 | 4 / 320 | 13.7× | 1.68e-4 | 4.49e-3 ✓ sig. |
| tissue homeostasis | GO:0001894 | 2 / 27 | 81.4× | 2.70e-4 | 6.28e-3 ✓ sig. |
| chromatin organization | GO:0006325 | 4 / 449 | 9.8× | 6.10e-4 | 1.09e-2 ✓ sig. |
| cell fate commitment involved in formation of primary germ layer | GO:0060795 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| beta-catenin-TCF complex assembly | GO:1904837 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| thrombocyte differentiation | GO:0002574 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| nucleate erythrocyte differentiation | GO:0043363 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| negative regulation of mRNA 3'-end processing | GO:0031441 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| regulation of heterochromatin formation | GO:0031445 | 1 / 1 | 1,099× | 9.10e-4 | 1.39e-2 ✓ sig. |
| cellular response to cAMP | GO:0071320 | 2 / 58 | 37.9× | 1.25e-3 | 1.66e-2 ✓ sig. |
| energy homeostasis | GO:0097009 | 2 / 64 | 34.4× | 1.52e-3 | 1.84e-2 ✓ sig. |
| protein homotetramerization | GO:0051289 | 2 / 66 | 33.3× | 1.61e-3 | 1.89e-2 ✓ sig. |
| endodermal-mesodermal cell signaling | GO:0003133 | 1 / 2 | 550× | 1.82e-3 | 2.02e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Hidradenoma | Mucoepidermoid carcinoma of submandibular gland | 0.235 | 4 | 7.59e-13 | 8.22e-12 ✓ sig. |
| Floor of mouth mucoepidermoid carcinoma | Mucoepidermoid carcinoma of submandibular gland | 0.167 | 3 | 3.62e-9 | 2.99e-8 ✓ sig. |
| Floor of mouth mucoepidermoid carcinoma | Warthin tumor | 0.400 | 2 | 5.00e-8 | 3.63e-7 ✓ sig. |
| Hidradenoma | Warthin tumor | 0.400 | 2 | 5.00e-8 | 3.63e-7 ✓ sig. |
| Floor of mouth mucoepidermoid carcinoma | Hidradenoma | 0.286 | 2 | 3.00e-7 | 1.96e-6 ✓ sig. |
| Mucoepidermoid carcinoma of submandibular gland | Warthin tumor | 0.118 | 2 | 1.00e-6 | 6.10e-6 ✓ sig. |
| Gestational trophoblastic disease | Hidradenoma | 0.200 | 1 | 2.58e-4 | 5.38e-4 ✓ sig. |
| Gestational trophoblastic disease | Mucoepidermoid carcinoma of submandibular gland | 0.059 | 1 | 1.03e-3 | 1.57e-3 ✓ sig. |